Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The website has removed the 'Last Update Posted (Estimated)' and now features a definitive 'Last Update Posted' section.
    Difference
    0.1%
    Check dated 2024-07-26T18:37:05.000Z thumbnail image
  2. Check
    yesterday
    Change Detected
    Summary
    A new publication detailing the results of a phase 2 study on lenvatinib plus pembrolizumab for advanced ovarian cancer has been added, along with an estimated last update for July 2024, while previous last update entries from October 2023 have been removed.
    Difference
    2%
    Check dated 2024-07-25T18:02:11.000Z thumbnail image
  3. Check
    2 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2024-07-24T16:48:29.000Z thumbnail image
  4. Check
    3 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, adding features to show more conditions and study numbers, and now includes information about 88 study locations.
    Difference
    0.3%
    Check dated 2024-07-23T15:15:14.000Z thumbnail image
  5. Check
    5 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-22T13:47:10.000Z thumbnail image
  6. Check
    7 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2024-07-20T10:38:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.